JUNIUS DANIEL M — SEC insider filings

SEC reporting owner CIK 1094159. 36 insider filings on record with FilingPulse; latest filed 2026-11-05.

Transaction summary — filings shown

Covers all 36 filings on record, filed 2020-08-21 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
IDEXX LABORATORIES INC /DE (IDXX)Director29—10 legs · 19,638 sh · $10,044,44948
GLYCOMIMETICS INC (GLYC)Director72 legs · 50,000 sh · $84,200—6

Insider filings — JUNIUS DANIEL M

FiledFormIssuerReported transactionsSource
2026-11-054IDEXX LABORATORIES INC /DE (IDXX)Sale (S): 700 @ $705.78 · Sale (S): 500 @ $701.68EDGAR
2026-05-144IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 525 (derivative) @ $0 · Grant/award (A): 234 (derivative) @ $0EDGAR
2026-05-114IDEXX LABORATORIES INC /DE (IDXX)Option exercise (M): 257 @ $0 · Option exercise (M): 257 (derivative)EDGAR
2025-05-144IDEXX LABORATORIES INC /DE (IDXX)Option exercise (M): 1,404 @ $245.79 · Option exercise (M): 1,279 @ $283.59 · Sale (S): 2,683 @ $506.41 · Option exercise (M): 1,404 (derivative) @ $0 · Option exercise (M): 1,279 (derivative) @ $0EDGAR
2025-05-084IDEXX LABORATORIES INC /DE (IDXX)Option exercise (M): 262 @ $0 · Option exercise (M): 262 (derivative) @ $0 · Grant/award (A): 600 (derivative) @ $0 · Grant/award (A): 257 (derivative) @ $0EDGAR
2024-05-084IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 609 (derivative) @ $0 · Grant/award (A): 262 (derivative) @ $0EDGAR
2024-05-014GLYCOMIMETICS INC (GLYC)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-04-024GLYCOMIMETICS INC (GLYC)Grant/award (A): 5,209 @ $3EDGAR
2024-02-014IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 14 @ $521.03EDGAR
2023-11-014IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 19 @ $396.39EDGAR
2023-08-014IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 14 @ $552.78EDGAR
2023-05-224GLYCOMIMETICS INC (GLYC)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2023-05-194IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 645 (derivative) @ $0 · Grant/award (A): 257 (derivative)EDGAR
2023-05-114GLYCOMIMETICS INC (GLYC)Purchase (P): 30,000 @ $1.56EDGAR
2023-05-024IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 13 @ $492.16EDGAR
2023-02-174IDEXX LABORATORIES INC /DE (IDXX)Option exercise (M): 2,187 @ $206.62 · Sale (S): 2,187 @ $511.68 · Option exercise (M): 2,187 (derivative)EDGAR
2023-02-014IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 14 @ $482.95EDGAR
2022-12-074IDEXX LABORATORIES INC /DE (IDXX)Option exercise (M): 3,046 @ $160.28 · Sale (S): 3,046 @ $424.91 · Option exercise (M): 3,046 (derivative)EDGAR
2022-11-184GLYCOMIMETICS INC (GLYC)Purchase (P): 20,000 @ $1.87EDGAR
2022-11-014IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 18 @ $364.28EDGAR
2022-08-024IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 16 @ $399.18EDGAR
2022-05-204GLYCOMIMETICS INC (GLYC)Grant/award (A): 21,000 (derivative) @ $0EDGAR
2022-05-134IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 344 (derivative) · Grant/award (A): 945 (derivative)EDGAR
2022-05-034IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 15 @ $430.48EDGAR
2022-02-014IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 13 @ $489.05EDGAR
2021-11-024IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 10 @ $666.14EDGAR
2021-08-124IDEXX LABORATORIES INC /DE (IDXX)Option exercise (M): 2,402 @ $85 · Sale (S): 2,402 @ $679.58 · Option exercise (M): 2,402 (derivative)EDGAR
2021-08-034IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 10 @ $678.53EDGAR
2021-05-274GLYCOMIMETICS INC (GLYC)Grant/award (A): 5,250 @ $0 · Grant/award (A): 10,500 (derivative) @ $0EDGAR
2021-05-244IDEXX LABORATORIES INC /DE (IDXX)Option exercise (M): 2,500 @ $85 · Sale (S): 2,500 @ $539.57 · Option exercise (M): 2,500 (derivative)EDGAR
2021-05-144IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 224 (derivative) · Grant/award (A): 723 (derivative)EDGAR
2021-05-044IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 11 @ $548.99EDGAR
2021-02-244IDEXX LABORATORIES INC /DE (IDXX)Option exercise (M): 898 @ $79.54 · Option exercise (M): 1,000 @ $85 · Sale (S): 10 @ $539.19 · Sale (S): 1,888 @ $538.57 · Option exercise (M): 898 (derivative) · Option exercise (M): 1,000 (derivative)EDGAR
2021-02-034IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 13 @ $478.68EDGAR
2020-11-024IDEXX LABORATORIES INC /DE (IDXX)Grant/award (A): 15 @ $424.82EDGAR
2020-08-214IDEXX LABORATORIES INC /DE (IDXX)Option exercise (M): 3,722 @ $63.95 · Sale (S): 3,722 @ $382.61 · Option exercise (M): 3,722 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1094159 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs